New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
MWN-AI** Summary
Progyny, Inc. recently released groundbreaking research focused on men's health and fertility, challenging longstanding societal perceptions that fertility issues are solely women's concerns. Conducted in partnership with Dynata, the study surveyed over 1,000 U.S. men aged 18-55. Key findings reveal that while an overwhelming majority of men recognize fertility as a shared responsibility—75% acknowledge it's not just a women's issue—significant barriers prevent many from pursuing necessary care. Dr. Janet Choi, Chief Medical Officer of Progyny, emphasized the need for a broader conversation that includes male health to improve fertility outcomes.
The research highlights several barriers: 64% of men cited fear of diagnosis, 56% financial stress, and 48% embarrassment as reasons for not seeking treatment, even though many are aware of their fertility-related conditions. Notably, while men demonstrate high knowledge levels, action is limited—less than half of those with fertility concerns discuss them with healthcare providers.
Moreover, the study revealed positive behavioral changes among men, with 56% adopting healthier lifestyles as they recognize the link between male infertility and overall health risks such as hormonal imbalances and diabetes. This underscores the importance of including men in fertility discussions early on for enhanced health outcomes.
For employers, trust is crucial, with only 21% of men expressing confidence in their employers as reliable sources for fertility information. This presents an opportunity for companies to strengthen their healthcare offerings by providing comprehensive fertility benefits. By fostering open dialogue around men’s fertility, employers can not only support their employees but also enhance workplace culture. Progyny’s benefits are designed to meet this need through resources tailored for men while promoting a more inclusive approach to family building.
MWN-AI** Analysis
The recent research from Progyny highlights a shifting narrative around men's roles in fertility, challenging conventional beliefs long dominated by women’s health perspectives. With increasing awareness—illustrated by 75% of men acknowledging that infertility is a shared responsibility—it's clear that men are becoming more engaged in the fertility conversation. Despite this awareness, barriers remain, notably social stigma, fear of diagnosis, and financial constraints, with nearly 80% of men not addressing fertility issues with healthcare providers despite having primary care access.
For investors in Progyny (Nasdaq: PGNY), this research signals a growing need for inclusive health services. As understanding of men's health in fertility expands, there's a unique opportunity for companies to differentiate themselves in the healthcare benefits landscape. The current sentiment among men indicates a readiness for comprehensive support, which Progyny aims to provide through dedicated resources and educational materials addressing male fertility.
Employers looking to attract and retain top talent could leverage this data to bolster benefits offerings. Solutions such as comprehensive family-building benefits can enhance employee satisfaction and retention, addressing a missing component in many workplace health conversations. Companies that build trust by offering transparent fertility support could considerably improve their workplace culture.
From a market perspective, Progyny is well-positioned to capitalize on this shift in mentality. Their business model, centered on providing inclusive fertility services, aligns with the increasing demand for holistic health support. As societal norms evolve, so too will the business landscape, opening avenues for growth for companies like Progyny.
Overall, investors should monitor the evolving dynamics of men's health in fertility and consider supporting firms that embrace these changes, as they are likely to yield long-term dividends in employee well-being and economic performance.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in family building solutions, today announced new men’s health research exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertility journey and the barriers that prevent many from getting the care they need for successful conception. The research, collected in partnership with Dynata – the world’s largest first-party data company for insights, activation, and measurement – captured insights from more than 1,000 U.S. men ages 18–55. While most men reported recognizing fertility as a shared responsibility between partners, social stigma, financial stress, and fear of a serious health diagnosis keep them from seeking care.
“For too long, society has viewed fertility solely as a women’s health issue, and now we’re finally seeing a shift in men’s awareness. Our research findings challenge conventional beliefs about men and fertility - revealing that men do want to be part of the conversation and solution, but certain barriers inhibit them from seeking care,” said Dr. Janet Choi, Chief Medical Officer, Progyny. “When society’s thinking and healthcare providers’ approach broadens to include men’s health from the start of the reproductive conversation, it will lead to better outcomes for everyone – partners, families, and workplaces alike.”
Key findings from Progyny’s study:
From fertility awareness to conversations with partners, the results revealed:
- Men are rejecting outdated stereotypes and embracing open dialogue : 75% say infertility isn’t just a women’s issue, and 82% feel comfortable discussing fertility with their partners – conversations many say have strengthened their relationships and deepened emotional intimacy.
- Knowledge is high, but action stalls: While two-thirds of men who have conceived or tried to conceive report having a fertility-related condition, fewer than half have spoken with a doctor about it, even though 80% had a primary care provider before trying to conceive. Of those men who had an appointment to follow up on their condition, most were comfortable seeing a urologist or fertility specialist and find the visits straightforward and easy.
When looking at how fertility concerns shape men’s health decisions, clear barriers emerge.
- Cost, fear of diagnosis, and embarrassment are key barriers: Among men looking to conceive, the top three reasons preventing them from seeking fertility treatment were fear of diagnosis (64%), financial stress (56%), and embarrassment of their symptoms (48%).
- Fertility can open the door to better health: Most men understand that male infertility is linked to overall health and 56% have already made proactive lifestyle changes such as improving diet, exercising, or quitting smoking and drinking.
“This research is a reminder that fertility is an essential part of men’s health,” said Dr. Joseph P. Alukal, Director of Men's Health at Columbia/New York-Presbyterian and member of Progyny’s Medical Advisory Board. “Male factors contribute to nearly half of infertility cases, and those issues can reveal underlying risks like hormonal imbalances, cancer, or diabetes. When men are part of the conversation early, it can make a real difference for their long-term health.”
The Impact to employers:
When it comes to healthcare – especially something as personal as fertility – trust matters. Progyny’s research shows that seven in ten men who have conceived or tried to conceive turn first to their primary care doctor or nurse for fertility information. Specialists, like urologists and reproductive endocrinologists, tie with general online search engines as their next most-used sources.
Additionally, Progyny’s research discovered that only 21% of men say they would trust their employer for fertility information, underscoring an opportunity for companies to rebuild credibility by offering transparent, comprehensive fertility benefits. These findings reveal clear steps for employers: consider offering a family building benefit and normalize conversations around men’s fertility and ensure they are equally included in care.
Progyny’s comprehensive fertility and family building benefits are designed to support all of those who wish to be parents – including dedicated resources for men, such as a reproductive urology network, diagnostic testing, and free online education materials. To learn more about Progyny’s fertility and family building solutions, visit Progyny.com/MensHealthSupport and join the conversation using #MensHealthMatters and #FertilityForAll .
About this research:
1,003 men ages 18-55; US residents; not employed in healthcare or market research; 74% employed full-time (40 hours/week+), 10% employed part-time (less than 40 hours/week), 9% temporarily unemployed or laid off and seeking work, 8% other were surveyed in June 2025 with a +/- 6.2% margin of error at a 95% confidence level.
601 men who have conceived or are trying to conceive (PATH 1) ages 18-55; US residents; not employed in healthcare or market research were surveyed in June 2025 with a +/- 8.0% margin of error at a 95% confidence level.
402 men who are not trying to conceive (PATH 2) ages 18-55; US residents; not employed in healthcare or market research were surveyed in June 2025 with a +/- 9.8% margin of error at a 95% confidence level.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Media:
Alexis Ford
media@progyny.com
Investors:
James Hart
investors@progyny.com
FAQ**
What specific strategies is Progyny Inc. (PGNY) implementing to address the barriers men face in seeking fertility care, as identified in their recent research findings?
How does Progyny Inc. (PGNY) plan to leverage the insights from their men's health research to enhance their family building benefit offerings for employers?
Given the study's results on men's views toward fertility, what steps will Progyny Inc. (PGNY) take to educate primary care providers about incorporating discussions on men's fertility into routine healthcare?
How might Progyny Inc. (PGNY) use the data collected from their survey to improve trust and engagement among men seeking fertility treatment and information through employer-sponsored benefits?
**MWN-AI FAQ is based on asking OpenAI questions about Progyny Inc. (NASDAQ: PGNY).
NASDAQ: PGNY
PGNY Trading
-4.94% G/L:
$17.32 Last:
553,999 Volume:
$17.65 Open:
